Lung transplantation (LTx) has traditionally been limited by a lack of suitable donor lungs.
With the recognition that lungs are more robust than initially thought, the size of the donor …

Lung transplantation (LTx) represents a life-saving therapy for patients with end-stage lung
disease. Since the first successful LTx, 50 years ago, 1 the number of patients listed for …

OBJECTIVES Donor organ shortage remains to be the major limitation in lung
transplantation, and donation after circulatory death (DCD) might represent one way to …

Background: Use of lungs donated after circulatory death (DCD) has expanded, but changes
in donor/recipient characteristics and comparison to brain dead donors (DBD) has not been …

Lung transplantation (LTx) has become a standard therapy with growing activity over the
years that improves the quantity and the quality of life for selected patients suffering from end …

The implementation of donation after circulatory death category 3 (DCD3) was one of the
attempts to reduce the gap between supply and demand of donor lungs. In the Netherlands …

Background Donation after cardiac death (DCD) to overcome the donor organ shortage is
well accepted in the clinical setting, although long-term outcome after DCD lung …

Background The number of lung transplants from donors after circulatory death has
increased over the last decade. This study aimed to describe the evolution and outcomes …

Background. Lung transplantations (LTx) have become an effective lifesaving treatment for
patients with end-stage lung diseases. While the shortage of lung donor pool and severe …

Background Lung transplantation remains the only treatment for end-stage lung disease.
Availability of suitable lungs does not parallel this growing trend. Centers using donation …